Treatment Strategy for Patients With RA-ILD

NCT07643038 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis Associated Interstitial Lung Disease

Interventions

DRUG: Tocilizumab
DRUG: Rituximab (RTX)
DRUG: Methotrexate

Sponsor

Chinese SLE Treatment And Research Group